Latest News
FDA grants rare paediatric disease designation to RedHill's opaganib
...
Bavarian Nordic secures DKK700m government vaccine contract
9 June 2026 - Denmark-based vaccines company Bavarian Nordic A/S (CPH:BAVA) announced on Tuesday that it has been awarded a government contract valued at more than DKK700m to supply its MVA-BN smallpox/mpox vaccine to an undisclosed country during 20...
GSK to acquire Nuvalent for USD10.6bn to expand lung cancer portfolio
9 June 2026 - Biopharmaceutical company GSK plc (LON:GSK) (NYSE:GSK) announced on Tuesday that it has entered an agreement to acquire Nuvalent Inc (NASDAQ:NUVL), a Boston-based clinical-stage biopharmaceutical company, in a USD10.6bn transaction aime...
Adcentrx Therapeutics' ADRX-0405 granted Chinese regulatory IND clearance to treat late-stage solid tumours
9 June 2026 - Adcentrx Therapeutics, a California-based clinical-stage biotechnology company advancing Antibody-Drug Conjugate (ADC) therapies for cancer treatment and other life-threatening diseases, announced on Monday that the China National Medic...
Galmed Pharmaceuticals to acquire Colospan for GI-focused platform development
9 June 2026 - Galmed Pharmaceuticals Ltd. (NASDAQ: GLMD), an Israeli pharmaceutical company, announced on Monday that it has entered into a definitive agreement to acquire Colospan Ltd., an Israeli commercial-stage medical device company that is clai...